Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 7
Submit an article Journal homepage
35
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Detection of Trisomy 8 in Donor-Derived Ph− Cells in a Patient with Ph+ Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation

Hermine Agis Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, AustriaCorrespondence[email protected]
,
Christine Mannhalter Department of Laboratory Medicine, Medical University of Vienna, Austria
,
Wolfgang R Sperr Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Austria
,
Felix Keil St.Anna Children's Hospital, Vienna, Austria
,
Peter Kalhs Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria
,
Hendrati Pirc-Danoewinata Department of Laboratory Medicine, Medical University of Vienna, Austria
,
Maria-Theresa Krauth Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Austria
,
Oskar A Haas St.Anna Children's Hospital, Vienna, Austria
,
Klaus Geissler Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria
,
Klaus Lechner Department of Laboratory Medicine, Medical University of Vienna, Austria
&
Peter Valent Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Austria
 show all
Pages 1453-1458 | Received 04 Feb 2004, Published online: 03 Aug 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Brigitte Schlegelberger, Gudrun Göhring, Felicitas Thol & Michael Heuser. (2012) Update on cytogenetic and molecular changes in myelodysplastic syndromes. Leukemia & Lymphoma 53:4, pages 525-536.
Read now
Peter Valent. (2007) Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches. Biologics: Targets and Therapy 1:4, pages 433-448.
Read now

Articles from other publishers (5)

Jasmine Candeliere, Aidan M. Kirkham, Risa Shorr, Gail Morris, Philip Berardi, Matthew D. Seftel & David S. Allan. (2022) Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure. Transplantation and Cellular Therapy 28:7, pages 408.e1-408.e8.
Crossref
Pedro Aurio Maia Filho, Tarcísio Paulo de Almeida Filho, Caroline de Fátima Aquino Moreina-Nunes, Rommel Rodriguez Burbano, José Alexandre Rodrigues de Lemos, Edivaldo Herculano Correa de Oliveira, Bruno Coêlho Cavalcanti, Jamilly Florêncio Pereira, Maritza Cavalcante Barbosa, Fernando Barroso Duarte, Marilena Facundo de Castro, Acy Telles de Souza Quixadá & Romélia Pinheiro Gonçalves Lemes. (2018) Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Environmental and Molecular Mutagenesis 59:3, pages 260-262.
Crossref
Gulsun Erdag, Jeanne M. Meck, Aurelia Meloni-Ehrig, Ludmila Matyakhina, Theresa Donohue, Ramaprasad Srinivasan, Philip Mowrey, JoAnn Kelly, Aleah Smith & Richard Childs. (2009) Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation. Cancer Genetics and Cytogenetics 190:2, pages 125-130.
Crossref
Peter Valent. (2008) Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease. British Journal of Haematology 142:3, pages 361-378.
Crossref
Bruno C. Medeiros, Kathy Chun, Suzanne Kamel‐Reid & Jeffrey Lipton. (2007) Inv (11)(p15q21) in donor‐derived Ph‐negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation. American Journal of Hematology 82:8, pages 758-760.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.